Effect of 7-day Bismuth Quadruple Therapy versus 14-day Moxifloxacin Triple Therapy for Second-line <i>Helicobacter pylori</i> Eradication Therapy.

pylori using clarithromycin-containing triple therapy, reported at 84.9-87.5% from 2001 to 2007 and 80.0-81.4% from 2008 to 2010 (p<0.0001), have shown a decreasing trend over the past 10 years in Korea. 4 Thus, a potent second-line regimen is required for successful H. pylori eradication.

also in 47,180 other papers